Metal release does not translate to increased metal allergy in metal-on-polyethylene THA .
OrthoEvidence Journal (OE Journal) - ACE Report
OE Journal. 2014;2(20):2 Acta Orthop. 2014 Aug;85(4):348-54. doi: 10.3109/17453674.2014.922730. Epub 2014 Jun 16.54 patients with primary osteoarthritis were randomized to undergo either reintroduced metal-on-metal (MOM) total hip resurfacing arthroplasty or metal-on-polyethylene (MOP) total hip arthroplasty, with the purpose of determining if the added excretion of metal ions from MOM results in heightened prevalence of metal allergies. A significant increase in cobalt and chromium in the MOM group was observed throughout the 5 year study period, but did not translate to increased metal allergy.
Was the allocation sequence adequately generated?
Was allocation adequately concealed?
Blinding Treatment Providers: Was knowledge of the allocated interventions adequately prevented?
Blinding Outcome Assessors: Was knowledge of the allocated interventions adequately prevented?
Blinding Patients: Was knowledge of the allocated interventions adequately prevented?
Was loss to follow-up (missing outcome data) infrequent?
Are reports of the study free of suggestion of selective outcome reporting?
Were outcomes objective, patient-important and assessed in a manner to limit bias (ie. duplicate assessors, Independent assessors)?
Was the sample size sufficiently large to assure a balance of prognosis and sufficiently large number of outcome events?
Was investigator expertise/experience with both treatment and control techniques likely the same (ie.were criteria for surgeon participation/expertise provided)?
Sì = 1
Incerto = 0,5
Non rilevante = 0
No = 0
La valutazione dei criteri di segnalazione valuta la trasparenza con cui gli autori riportano le caratteristiche metodologiche e sperimentali dello studio all'interno della pubblicazione. La valutazione è suddivisa in cinque categorie che vengono presentate di seguito.
3/4
Aleatorización
2/4
Medición de resultados
4/4
Inclusión / exclusión
4/4
Descripción de la terapia
4/4
Estadísticas
Detsky AS, Naylor CD, O'Rourke K, McGeer AJ, L'Abbé KA. J Clin Epidemiol. 1992;45:255-65
L'Indice di Fragilità è uno strumento che aiuta l'interpretazione dei risultati significativi, fornendo una misura della forza di un risultato. L'Indice di Fragilità rappresenta il numero di eventi consecutivi che devono essere aggiunti a un risultato dicotomico per rendere il risultato non più significativo. Un numero piccolo rappresenta un risultato più debole, mentre un numero grande rappresenta un risultato più forte.
Perché questo studio era necessario ora?
Metal-on-metal (MOM) total hip arthroplasties were the standard of care in the 1960's and 1970's, but researchers soon discovered MOM implants released high levels of cobalt, chromium, and nickel. Focus shifted towards metal-on-polyethylene (MOP) arthroplasties instead, which were later found to have a high incidence of osteolysis and aseptic loosening in young, active patients, which many consider an even greater problem. Consequently, MOM arthroplasties were reintroduced, but the risk of metal hypersensitivity has become an issue due to greater absolute number of wear particles. Based on the hypothesis that metal allergies can be caused by prolonged metal exposure, the aim of this study was to determine if MOM arthroplasties increased the incidence of metal allergies in exposed patients.
Qual era la domanda di ricerca principale?
Is there greater incidence of metal allergy in patients undergoing metal-on-metal total hip resurfacing arthroplasty compared to patients undergoing metal-on-polyethylene total hip arthroplasty 5 years post-surgery?
- A significant 10- to 20- fold increase in cobalt and chromium was observed in the urine of the MOM group throughout the 5 year follow-up (p<0.05), while no differences were observed in patients receiving implants with MOP or COP.
- The patch test revealed no significant difference in the incidence of metal hypersensitivity at 5 years between the MOM and MOP/COP groups, nor between MOP and COP patients (both p>0.05).
- The lymphocyte transformation assay revealed no significant difference in cellular reactivity at 5 years between the MOM and MOP/COP groups, nor between MOP and COP patients (both p>0.05).
Che cosa devo ricordare di più?
The significant increase of cobalt and chromium levels throughout the 5 year study period did not translate to increased metal allergy in patients that underwent metal-on-metal (MOM) total hip arthroplasty.
Come influenzerà l'assistenza ai miei pazienti?
It appears MOM total hip arthoplasty does not increase the incidence of metal allergies, but the long-term effects of metal exposure still remain uncertain. Results must be interpreted with caution, as the metel-on-metal group lost 7 patients to final follow-up.
DISCLAIMER
Il contenuto di questa pagina è solo a scopo informativo e non intende sostituire la consulenza, la diagnosi o il trattamento medico professionale. Se ha bisogno di cure mediche, si rivolga sempre al suo medico o al pronto soccorso più vicino. Le opinioni, le convinzioni e i punti di vista espressi dalle persone sui contenuti presenti in questa pagina non riflettono le opinioni, le convinzioni e i punti di vista di OrthoEvidence.
0 di 4 articoli mensili GRATUITI sbloccati
